Tocilizumab for treatment of SARS-CoV-2 infection at home: A case report.

McGlen, S E; Stoesser, N; Woodrow, C; Dudley, J; Newton, D; Lasserson, D

McGlen, S E; Stoesser, N; Woodrow, C; Dudley, J; Newton, D; Lasserson, D.

Afiliação

McGlen SE; MPharm, Oxford University Hospitals NHS Foundation Trust.
Stoesser N; DPhil, Oxford University Hospitals NHS Foundation Trust and Nuffield Department of Medicine, University of Oxford.
Woodrow C; MRCP, PhD, Oxford Univeristy Hospitals NHS Foundation Trust and Medical Sciences Division University of Oxford.
Dudley J; RN, BSc, Oxford University Hospitals NHS Foundation Trust.
Newton D; D.Sc.
Lasserson D; MD FRCPEdin, Oxford University Hospitals NHS Foundation Trust and Warwick Medical School, University of Warwick.

Acute Med ; 21(1): 53-55, 2022.

Article em En | MEDLINE | ID: mdl-35342912

RESUMO

SARS-CoV-2 virtual wards have successfully developed to monitor and escalate patients to hospital throughout the pandemic. Here we describe the case of an 84 year old man who received his complete care for severe SARS-CoV-2 pneumonitis at home, including the administration of oxygen, dexamethasone and tocilizumab.

Assuntos

Tratamento Farmacológico da COVID-19; Idoso de 80 Anos ou mais; Anticorpos Monoclonais Humanizados; Humanos; Masculino; SARS-CoV-2

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Limite: Aged80 / Humans / Male Idioma: En Revista: Acute Med Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google